1. Home
  2. SLBT vs MAX Comparison

SLBT vs MAX Comparison

Compare SLBT & MAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SL Science Holding Limited Ordinary Shares

SLBT

SL Science Holding Limited Ordinary Shares

N/A

Current Price

$0.54

Market Cap

644.9M

Sector

N/A

ML Signal

N/A

Logo MediaAlpha Inc.

MAX

MediaAlpha Inc.

N/A

Current Price

$13.50

Market Cap

657.4M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
SLBT
MAX
Founded
N/A
2014
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
644.9M
657.4M
IPO Year
2025
2020

Fundamental Metrics

Financial Performance
Metric
SLBT
MAX
Price
$0.54
$13.50
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
★ $15.86
AVG Volume (30 Days)
46.5K
★ 1.1M
Earning Date
10-26-2026
10-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 25.81
EPS
N/A
★ 1.32
Revenue
N/A
★ $1,113,600,000.00
Revenue This Year
N/A
$22.43
Revenue Next Year
N/A
$10.60
P/E Ratio
★ N/A
$10.48
Revenue Growth
N/A
★ 28.78
52 Week Low
$0.57
$7.09
52 Week High
$6.25
$15.99

Technical Indicators

Market Signals
Indicator
SLBT
MAX
Relative Strength Index (RSI) 22.09 53.01
Support Level N/A $13.68
Resistance Level $1.75 $14.42
Average True Range (ATR) 0.13 0.80
MACD -0.01 -0.19
Stochastic Oscillator 4.94 7.05

Price Performance

Historical Comparison
SLBT
MAX

About SLBT SL Science Holding Limited Ordinary Shares

SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.

About MAX MediaAlpha Inc.

MediaAlpha Inc provides a platform that enables insurance carriers and distributors to target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It serves as a customer acquisition channel in property and casualty insurance, health insurance, and life insurance. The company operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.

Share on Social Networks: